{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:40:17Z","timestamp":1793731217310,"version":"4.6.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jim.2018.11.002","type":"journal-article","created":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T21:35:30Z","timestamp":1541194530000},"page":"87-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Validation of an ADCC assay using human primary natural killer cells to evaluate biotherapeutic products bearing an Fc region"],"prefix":"10.1016","volume":"464","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4971-9262","authenticated-orcid":false,"given":"Edith","family":"Gonz\u00e1lez-Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Camacho-Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Jim\u00e9nez-Uribe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Montes-Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilselena","family":"Cort\u00e9s-Paniagua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jazm\u00edn","family":"S\u00e1nchez-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Mu\u00f1oz-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra V.","family":"Tenorio-Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"L\u00f3pez-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9717-0265","authenticated-orcid":false,"given":"Marco A.","family":"Velasco-Vel\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenin","family":"Pav\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia Mayra","family":"P\u00e9rez-Tapia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8862-1378","authenticated-orcid":false,"given":"Emilio","family":"Medina-Rivero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2018.11.002_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/ph3010146","article-title":"Impact of glycosylation on effector functions of therapeutic IgG","author":"Ab\u00e8s","year":"2010","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jim.2018.11.002_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2008.11.008","article-title":"Differences in binding and effector functions between classes of TNF antagonists","author":"Arora","year":"2009","journal-title":"Cytokine"},{"key":"10.1016\/j.jim.2018.11.002_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2014.07.010","article-title":"Development of a robust reporter-based ADCC assay with frozen, thaw-and-use cells to measure Fc effector function of therapeutic antibodies","author":"Cheng","year":"2014","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2018.11.002_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/S0165-2478(01)00226-7","article-title":"Three-color flow cytometric assay for the study of the mechanisms of cell-mediated cytotoxicity","author":"Derby","year":"2001","journal-title":"Immunol. Lett."},{"issue":"2","key":"10.1016\/j.jim.2018.11.002_bb0025","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.abb.2012.02.011","article-title":"Mechanism of action of therapeutic monoclonal antibodies: promises and pitfalls of in vitro and in vivo assays","volume":"526","author":"Golay","year":"2012","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jim.2018.11.002_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2017.06.004","article-title":"Surrogate CD16-expressing effector cell lines for determining the bioactivity of therapeutic monoclonal antibodies","author":"Gurjar","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jim.2018.11.002_bb0035","article-title":"Fucosylation of a therapeutic antibody: effects on antibody-dependent, cell-mediated cytotoxicity (ADCC) potency and efficacy","author":"Ho","year":"2016","journal-title":"BioProcess International"},{"key":"10.1016\/j.jim.2018.11.002_bb0040","doi-asserted-by":"crossref","DOI":"10.1080\/14712598.2016.1217329","article-title":"Characterization and non-clinical assessment of the proposed etanercept biosimilar GP2015 with originator etanercept (Enbrel\u00ae)","author":"Hofmann","year":"2016","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.jim.2018.11.002_bb0045","doi-asserted-by":"crossref","DOI":"10.1007\/s12033-012-9531-x","article-title":"Generation and comparative characterization of glycosylated and aglycosylated human IgG1 antibodies","author":"Hristodorov","year":"2013","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.jim.2018.11.002_bb0050","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1182\/blood.V90.3.1109","article-title":"Fc gammaRIIIa-158V\/F polymorphism influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of Fc gammaRIIIa-48L\/R\/H phenotype","volume":"90","author":"Koene","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jim.2018.11.002_bb0055","doi-asserted-by":"crossref","DOI":"10.2217\/imt.12.38","article-title":"Combination strategies to enhance antitumor ADCC","author":"Kohrt","year":"2012","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jim.2018.11.002_bb0060","doi-asserted-by":"crossref","DOI":"10.1111\/j.1349-7006.2009.01222.x","article-title":"Engineered therapeutic antibodies with improved effector functions","author":"Kubota","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jim.2018.11.002_bb0065","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3908289","article-title":"A novel system for the quantification of the ADCC activity of therapeutic antibodies","author":"Lallemand","year":"2017","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jim.2018.11.002_bb0070","article-title":"Analytical similarity assessment of rituximab biosimilar CT-P10 to reference medicinal product","author":"Lee","year":"2018","journal-title":"MAbs"},{"key":"10.1016\/j.jim.2018.11.002_bb0075","doi-asserted-by":"crossref","DOI":"10.1002\/art.23447","article-title":"Mechanisms for cytotoxic effects of anti-tumor necrosis factor agents on transmembrane tumor necrosis factor\u202f??-expressing cells: Comparison among infliximab, etanercept, and adalimumab","author":"Mitoma","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jim.2018.11.002_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/ibd.20225","article-title":"Mechanism of action of certolizumab pegol (CDP870): in vitro comparison with other anti-tumor necrosis factor \u03b1 agents","author":"Nesbitt","year":"2007","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.jim.2018.11.002_bb0085","doi-asserted-by":"crossref","DOI":"10.4161\/mabs.19873","article-title":"Development and validation of an antibody-dependent cell-mediated cytotoxicity-reporter gene assay","author":"Parekh","year":"2012","journal-title":"MAbs"},{"key":"10.1016\/j.jim.2018.11.002_bb0090","doi-asserted-by":"crossref","DOI":"10.1111\/j.1600-6143.2006.01288.x","article-title":"Rituximab, an anti-CD20 monoclonal antibody: history and mechanism of action","author":"Pescovitz","year":"2006","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jim.2018.11.002_bb0095","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2017.1286435","article-title":"A high-performance, non-radioactive potency assay for measuring cytotoxicity: a full substitute of the chromium-release assay targeting the regulatory-compliance objective","author":"Rossignol","year":"2017","journal-title":"MAbs"},{"key":"10.1016\/j.jim.2018.11.002_bb0100","series-title":"Cancer Cell Signaling. Methods in Molecular Biology (Methods and Protocols)","article-title":"A flow cytometry-based assay for the evaluation of antibody-dependent cell-mediated cytotoxicity (ADCC) in cancer cells","volume":"vol. 1165","author":"Salinas-Jazm\u00edn","year":"2014"},{"key":"10.1016\/j.jim.2018.11.002_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2017.11.002","article-title":"An improved method to quantify human NK cell-mediated antibody-dependent cell-mediated cytotoxicity (ADCC) per IgG FcR-positive NK cell without purification of NK cells","author":"Sung","year":"2018","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2018.11.002_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095787","article-title":"Development of a cell-based assay measuring the activation of Fc\u03b3RIIa for the characterization of therapeutic monoclonal antibodies","author":"Tada","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jim.2018.11.002_bb0115","doi-asserted-by":"crossref","DOI":"10.1172\/JCI119616","article-title":"A novel polymorphism of Fc\u03b3RIIIa (CD16) alters receptor function and predisposes to autoimmune disease","author":"Wu","year":"1997","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jim.2018.11.002_bb0120","doi-asserted-by":"crossref","DOI":"10.1038\/srep19772","article-title":"A novel method for evaluating antibody-dependent cell-mediated cytotoxicity by flowcytometry using cryopreserved human peripheral blood mononuclear cells","author":"Yamashita","year":"2016","journal-title":"Sci. Rep."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175918302072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175918302072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:26:22Z","timestamp":1762205182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175918302072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":24,"alternative-id":["S0022175918302072"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2018.11.002","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of an ADCC assay using human primary natural killer cells to evaluate biotherapeutic products bearing an Fc region","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2018.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}